FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Markey, Warren Introduce Medical Device Tax Repealer

Sens. Markey and Warren reintroduce legislation to eliminate the medical device excise tax approved as part of the Affordable Care Act.

Human Drugs

Wuhan Chinese Moxibustion CGMP Violations Cited

FDA warns Wuhan Chinese Moxibustion Technology about CGMP violations in its production of finished pharmaceuticals.

Human Drugs

Open FDA Plans for Nonbiological Complex Drugs: GAO

FDA says it is working to implement a GAO report recommendation calling for communication of plans to issue or revise product-specific guidances for c...

Medical Devices

FDA Proposes Medical Device Review Regulation

FDA proposes regulations covering internal agency supervisory review of some decisions on medical devices regulated by CDRH.

Human Drugs

Dont Harm FDAs Expanded Access Program: Public Citizen

Public Citizens Michael Carome says Congress should pass legislation to enhance FDAs expanded access program rather than right-to-try legislation that...

Human Drugs

CGMP Violations at Australias Delta Laboratories

FDA warns Australias Delta Laboratories about CGMP violations in its production of finished pharmaceuticals.

Federal Register

Guide on UDI Enforcement Discretion for Certain Devices

Federal Register notice: FDA makes available a guidance entitled Unique Device Identification: Policy Regarding Compliance Dates for Class I and Uncla...

Federal Register

Workshop on Device Conformity Assessment to Recognized Standards

Federal Register notice: FDA announces a 5/22-23 public workshop on Accreditation Scheme for Conformity Assessment of Medical Devices to FDA-Recognize...

Federal Register

Rule on Intended Use Changes Delayed for More Consideration

Federal Register notice: FDA proposes to delay the effective date of certain portions of a final rule that amended the agencys existing regulations de...

Human Drugs

FDA, Defense Dept. Launch Drug Development Program

FDA starts a collaborative program with the Defense Department to prioritize development and approval of medical products needed by U.S. troops.